Patents Assigned to Aperisys, Inc.
  • Patent number: 11718683
    Abstract: The invention relates to fusion proteins comprising an antigen binding domain fused with a modified heat shock 70 protein. The invention further relates to methods of using the fusion proteins to induce an immune response to antigens and to treat diseases associated With antigens.
    Type: Grant
    Filed: August 5, 2019
    Date of Patent: August 8, 2023
    Assignees: Aperisys, Inc., The General Hospital Corporation
    Inventors: Timothy Brauns, Mark C. Poznansky, Jeffrey A. Gelfand, Huabiao Chen, Stephen J. McCormack